Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case report

Abstract Background With advances in breast cancer treatment, the importance of de-escalation therapy to reduce harm during the treatment of elderly patients has attracted attention in recent years. Certain patient populations are expected to have a superior response to anti-HER2 drugs, particularly...

Full description

Bibliographic Details

Published in:	Surgical Case Reports
Main Authors:	Ayaka Isogai, Haruru Kotani, Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, Ayumi Kataoka, Kazuki Nozawa, Yuri Ozaki, Yuka Endo, Akira Nakakami, Rie Komaki, Hiroji Iwata
Format:	Article
Language:	English
Published:	Japan Surgical Society 2023-06-01
Subjects:	Breast cancer HER2-positive Trastuzumab Monotherapy Single dose
Online Access:	https://doi.org/10.1186/s40792-023-01661-4